Past EventBeyond Borders: Ernst & Young’s State of the Life Science Industry Report

Over the last 26 years, EY’s Beyond Borders has provided a comprehensive look at the biotech industry’s issues and challenges — from constrained venture capital to cool public markets to concerns that future generations of companies might not be able to go the distance. Beyond Borders also chronicled the industry’s tremendous dynamism and the significant number of companies that have been able to beat the odds and make the journey to sustainability. Beyond borders 2012 continues to explore biotech’s story as pressures on the business model increase to extraordinary levels. Please join us on August 14, 2012 for a presentation of Ernst & Young’s 2012 Beyond Borders report by Jim Wilson, Partner and Phil Howard, Senior Manager of Ernst & Young’s Life Sciences practice.

About Ernst & Young’s Global Life Sciences Center

Ernst & Young’s Global Life Sciences Center brings together a worldwide team of professionals to help life sciences companies address their challenges at every stage of development. From the emerging biotech or medtech firm to the well-established, global pharmaceutical company, our industry teams bring deep experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends, identify implications and develop points of view on relevant industry issues. Whether it’s forming innovative alliances, improving operations, new regulations or exploring new markets, we can give you a clear perspective on how to drive value in an increasingly complex, competitive and risk-driven environment. It’s how Ernst & Young makes a difference.

Our Presenters:

Jim Wilson, Partner; Ernst & Young, Denver CO

  • 15 years of experience serving clients in life sciences and technology related industries.
  • Clients have ranged from emerging companies to large, multinational, publicly traded companies
  • E&Y Entrepreneur Of The Year program director for the Mountain Desert region, with a long history of working with growth companies
  • Member of the Board of Directors and Audit Committee of the Colorado Bioscience Association
  • Experienced with public offerings and acquisitions
  • Experienced with financial reporting for both private and public companies
  • CPA licensed in Colorado

Phil Howard, Senior Manager; Ernst & Young, Phoenix, AZ

  • 9 years of experience serving clients in life science and healthcare related industries
  • Clients have ranged from emerging companies to large, multinational, publicly traded companies
  • Serves as E&Y Global Life Science Center Audit Resident, where he consults with clients and engagement teams on auditing, tax accounting and financial statement reporting issues in addition to developing thought leadership for E&Y’s Global Life Science practice
  • Member of the Board of Directors, Treasurer of the Arizona Bioindustry Association and Tempe Chamber of Commerce
  • Experienced with public offerings and acquisitions
  • Experienced with financial reporting for both private and public companies
  • CPA licensed in Arizona
Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

Curia Global

Curia Global

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories

Colliers

Colliers